跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Emitron
Approved
STANDARD
Emitron
Cisen Pharmaceutical Co., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
7afa8d5d768bc3ee
Company
Cisen Pharmaceutical Co., Ltd.
Type
Standard
Approval Details
Approval Id
7afa8d5d768bc3ee
Drug Approval Philippines Name
Emitron
Product Name
Emitron
Registration Number
DRP-7505
Brand Name
Emitron
Generic Name
Ondansetron (As Hydrochloride)
Dosage Form
Solution For Injection (IM/IV)
Dosage Strength
2mg/mL (8mg/4mL)
Manufacturer
Cisen Pharmaceutical Co., Ltd.
Importer
Endure Medical, Inc.
Distributor
Endure Medical, Inc.
Company Detail Path
/organization/cisen-pharmaceutical-co-ltd-jining-shandong-china
Issuance Date
07 June 2021
Expiry Date
27 May 2026
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
7afa8d5d768bc3ee
Type
Standard
Back to Philippines FDA Approvals
Emitron - Philippines FDA Drug Approval Details